山东威高集团医用高分子制品股份有限公司（01066）于2026年2月16日发布翌日披露报表，公告显示公司于当日回购H股62,000股，约占变动前已发行股份（不包括库存股份）总数的0.0014%。回购每股价格介乎5.06港元至5.10港元，总成交金额为315,920港元。
回购完成后，公司已发行股份（不包括库存股份）数量为4,480,870,324股，库存股份数量增至41,462,000股。公司于2025年5月27日通过回购授权，可回购股份总数为451,560,392股，截至目前累计已回购34,813,600股，占当日已发行股份（不包括库存股份）总数的7.7096%。
公司确认本次股份回购过程遵守香港联合交易所证券上市规则及相关法律法规。公告由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.